A new drug could be more effective at cutting stroke risk, and lessening bleeding and mortality after the cardiovascular event than the commonly prescribed warfarin, a new study suggests.
Anticoagulant medication apixaban not only reduced the risk of stroke, but it resulted in 31 per cent less bleeding and an 11 per cent lower death rate than when wayfarin was used, according to the study published in the New England Journal of Medicine.
Lead author Christopher B Granger explained that the new drug is also advantageous as it does not require monitoring and is less likely to react to foods or other drugs than wayfarin.
"These are important findings because they show that, when compared to warfarin, a very effective treatment to prevent stroke, apixaban resulted in an additional 21 percent relative reduction in stroke or systemic embolism," he said.
In other news, individuals with a history of depression could be at a higher risk of stroke, according to a study published in journal Stroke.
Find the nearest Barchester care home.